Jazz Pharmaceuticals plc (JAZZ), Thursday announced the decision to appoint Chief Operating Officer Renee Gala as the company's President and Chief Executive Officer, effective August 11, 2025.
The decision comes as CEO Bruce Cozadd informed the board in 2024 of his intent to retire from the position upon the selection of his successor.
Prior to Jazz, Gala served as senior vice president and CFO of Theravance Biopharma, Inc.
In the pre-market hours, Jazz's stock is trading at $111.50, down 0.09 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.